From our early breakthroughs to our most recent achievements, explore the milestones that have shaped our innovative path.

Less than 14% of gene therapies succeed due to off-target effects causing harm.

Re:Pair treats regulatory DNA like a mini GPS: it steers expression toward the cell types and contexts you intend—improving targeting confidence and safety before you commit to expensive synthesis and in vivo work. We focus on compact synthetic promoters and enhancers you can manufacture and iterate quickly, with ranked outputs and documentation structured for a one-day design turnaround on agreed scopes.